Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-05

Clinical Trial Update: Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating minocycline and celecoxib as adjunctive treatments for bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)
  • Minocycline (minocycline)

Snippet

Sponsor: Pakistan Institute of Living and Learning | Conditions: Depression, Bipolar Disorder | Phase 3 | Status: COMPLETED